The global Vacuum Blood Collection Devices Market is anticipated to reach US$ 2.3 billion in 2021, growing at a 6.3% CAGR during the forecast period (2021 to 2031). Increasing blood transfusion, rising blood test usage, rising demand for dependable and safe blood collection equipment, and rising use of aseptic procedures to provide better patient care will boost the vacuum blood collection devices market.
With an increase in the number of blood tests performed for the detection of chronic diseases such as HIV, anaemia, diabetes, and cardiovascular disease, sales of vacuum blood collection systems are expected to reach US$ 4.2 billion by the end of 2031.
Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5363
These tubes have improved sampling by allowing sample collection through single venipuncture.
Ease in the process of blood collection, processing and the lowering risk of contamination to the patients are the major factor driving the market growth.
Global burden of chronic diseases such as, cardiovascular disorders, cancer, and diabetes has increased at a rapid pace.
High prevalence of these diseases has enforced adherence to the regular health checkups and growing importance of markers for early diagnosis via blood tests.
As blood tests are primary mode of diagnosis for these diseases, the rise in number of chronic diseases will positively drive the demand for vacuum blood collection devices, augmenting the market growth.
Rising advancements in the field of biotechnology have enabled the establishment of several non-invasive approaches for disease diagnosis.
Amongst other favorable diagnostic tools, liquid biopsy has emerged as a promising and versatile non-invasive cancer diagnostic tool.
Liquid biopsy analysis based on circulating cell-free nucleic acids, circulating tumor cells or other diseased cells from organs, and exosomes or other micro vesicles in blood offer new means for non-invasive diagnostic applications.
With growing number of stabilizing reagents and dedicated vacuum blood collection tubes available in the market, it has become possible to perform the post-collection preservation of circulating cell-free DNA (cfDNA) profiles in whole blood.
Last few days to get reports at discounted prices, offer expires soon!
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-5363
Key Takeaways from Vacuum Blood Collection Devices Study
- By product, serum separator tubes will account for the largest share of 23.2% in 2021, and is expected to remain dominant throughout the forecast period.
- Based on material, plastic/PET material will hold mammoth’s share of 84.5% in 2021
- In terms of application, routine chemistry is expected to account for the largest share of 34.2% in 2021 of vacuum blood collection devices market and is expected to continue to grow at the same trend during the forecast period.
- Diagnostic laboratories are expected to be the primary end-user of vacuum blood collection devices, holding total market share of 46.6% in 2021
- The U.S. is expected to emerge as the most lucrative market across North America, capturing 87.3% of market share.
- India will lead the growth of South Asia’s vacuum blood collection devices market, contributing for over 74.6% of sales through 2031
The key market players covered by FMI include Becton, Dickinson, & Company, Greiner Bio-One GmbH, Guangzhou Improve Medical Instruments Co.,Ltd, AB Medical, Inc., SARSTEDT AG & Co. KG, Cardinal Health, Poly Medicure Ltd, FL Medical , InterVac Technology, CHENGDU RICH SCIENCE INDUSTRY CO., LTD., Zhejiang Gongdong Medical Technology Co., Ltd., Aptaca Spa., Hindustan syringes & Medical Devices.
More Insights Available
This region holds the largest share of the blood collection devices market. This can be attributed to the high prevalence of chronic diseases, increasing demand for blood and blood products, and the presence of major players in the market. The United States is the largest market in this region due to its well-established healthcare infrastructure and high healthcare spending.
Customization Available Upon Request@ https://www.futuremarketinsights.com/customization-available/rep-gb-5363
Vacuum Blood Collection Devices by Category
By Product:
- Serum Separation Tubes
- Serum Clot Activators/Serum Gel + Clot Activator
- Silica
- Thrombin
- Plasma Analysis/Anti-coagulants
- EDTA Tubes
- Lithium Heparin
- Sodium Heparin
- Coagulation Analysis Tubes
- Glucose Analysis Tubes
- Sodium Fluoride
- Potassium Fluoride
- Fluoride Oxide
- Others
By Material:
- PET/Plastic
- Glass
By Application:
- Serology & Immunology
- Routine Chemistry
- Blood Typing
- Molecular Genetics
- Blood Sugar Assay
- Others
By End User:
- Diagnostic Centers
- Hospitals & Clinics
- Research & Academic Institutes
- Veterinary Hospitals & Clinics
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs